Surveys of patients and their surgeons showed genetic testing rates ranged from 26 to 72 percent, depending on the surgeon.

In a new study of breast cancer patients who had breast reconstruction, researchers examine complications across the different types of surgeries.

Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting a precision medicine approach.

Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.

Researchers have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.

A surprising finding explains how a crucial cancer gene impacts cell signaling to drive cancer growth.